Clinical Relevance of Computed Tomography Perfusion-Estimated Infarct Volume in Acute Ischemic Stroke Patients within the 6-h Therapeutic Time Window
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Bo Kyu | - |
dc.contributor.author | Kim, Byungjun | - |
dc.contributor.author | You, Sung-Hye | - |
dc.date.accessioned | 2022-08-15T02:40:16Z | - |
dc.date.available | 2022-08-15T02:40:16Z | - |
dc.date.created | 2022-08-12 | - |
dc.date.issued | 2022 | - |
dc.identifier.issn | 1015-9770 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/143219 | - |
dc.description.abstract | Introduction: Although the estimated infarct volume on baseline computed tomography perfusion (CTP) can identify patients who are likely to benefit from endovascular thrombectomy (EVT) in late time window strokes, the role of CTP imaging in early time windows has not been established. We assessed the clinical impact of CTP-estimated infarct volume on long-term prognosis after EVT, particularly in patients with early time window stroke. Methods: We retrospectively reviewed patients who underwent pretreatment CTP and EVT for large vessel occlusion in the anterior circulation within 6 h after symptom onset between March 2014 and February 2019. The infarct volume at baseline CTP was estimated using commercially available software (RAPID, iSchemaView, Menlo Park, CA, USA) with a cerebral blood flow threshold <30% of the normal brain. Risk factors for poor outcome after EVT were evaluated, and a receiver operating characteristic (ROC) curve analysis was used to identify CTP-estimated infarct volumes that optimally predicted the development of symptomatic intracranial hemorrhage (sICH) and poor outcomes (modified Rankin Scale [mRS] 3-6) at 90 days. Results: Of 120 patients, successful recanalization was achieved in 89 (74.2%) patients, while 61 (50.8%) showed poor outcomes at 90 days. Among 89 patients with successful recanalization after EVT, age, diabetes, clinical stroke severity, CTP-estimated infarct volume, and sICH development were independently associated with 90-day clinical outcomes. ROC analysis identified infarct volumes of >= 88.5 mL and >= 74 mL as the optimal thresholds for predicting poor outcome and development of sICH, respectively. Patients with large infarct volumes showed poorer outcomes (odds ratio [OR], 7.704; 95% confidence interval [CI], 1.528-38.839) and higher rates of sICH development (OR, 10.857; 95% CI, 1.835-64.235). Among patients with large infarction volumes (>= 88.5 mL), the 90-day mRS demonstrated a shift toward better outcomes in patients with successful recanalization. Conclusion: Larger initial infarct volumes are significantly associated with worse clinical outcomes in patients who underwent EVT because of early time window stroke. Furthermore, our study of 6-h data demonstrated that an initial infarction of more than a certain volume might be an independent risk factor for sICH development and poor outcomes even in patients with successful recanalization. However, we still observed benefits of EVT in patients with large ischemic cores. The CTP-estimated infarct volume might be an important prognostic factor after EVT rather than a biomarker predicting treatment effectiveness. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KARGER | - |
dc.subject | CEREBRAL-BLOOD-FLOW | - |
dc.subject | ENDOVASCULAR THROMBECTOMY | - |
dc.subject | CT PERFUSION | - |
dc.subject | SELECTION | - |
dc.subject | METAANALYSIS | - |
dc.subject | REPERFUSION | - |
dc.subject | THRESHOLDS | - |
dc.subject | SOLITAIRE | - |
dc.subject | BENEFIT | - |
dc.title | Clinical Relevance of Computed Tomography Perfusion-Estimated Infarct Volume in Acute Ischemic Stroke Patients within the 6-h Therapeutic Time Window | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Byungjun | - |
dc.identifier.doi | 10.1159/000519901 | - |
dc.identifier.scopusid | 2-s2.0-85124084860 | - |
dc.identifier.wosid | 000748010100001 | - |
dc.identifier.bibliographicCitation | CEREBROVASCULAR DISEASES, v.51, no.4, pp.438 - 446 | - |
dc.relation.isPartOf | CEREBROVASCULAR DISEASES | - |
dc.citation.title | CEREBROVASCULAR DISEASES | - |
dc.citation.volume | 51 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 438 | - |
dc.citation.endPage | 446 | - |
dc.type.rims | ART | - |
dc.type.docType | Article; Early Access | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
dc.relation.journalWebOfScienceCategory | Clinical Neurology | - |
dc.relation.journalWebOfScienceCategory | Peripheral Vascular Disease | - |
dc.subject.keywordPlus | CEREBRAL-BLOOD-FLOW | - |
dc.subject.keywordPlus | ENDOVASCULAR THROMBECTOMY | - |
dc.subject.keywordPlus | CT PERFUSION | - |
dc.subject.keywordPlus | SELECTION | - |
dc.subject.keywordPlus | METAANALYSIS | - |
dc.subject.keywordPlus | REPERFUSION | - |
dc.subject.keywordPlus | THRESHOLDS | - |
dc.subject.keywordPlus | SOLITAIRE | - |
dc.subject.keywordPlus | BENEFIT | - |
dc.subject.keywordAuthor | Stroke | - |
dc.subject.keywordAuthor | Malignant profile | - |
dc.subject.keywordAuthor | Futile recanalization | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.